July 24, 2025 July 24, 2025Categories Trial ResultsTrial Results: ECOG-ACRIN research round-up – Summer 2025Takeaways from ECOG-ACRIN trials presented at the 2025 American Society of Clinical Oncology Annual Meeting
July 2, 2024 July 2, 2024Categories Trial ResultsECOG-ACRIN research round-up – Summer 2024Takeaways from ECOG-ACRIN trial results presented at the 2024 American Society of Clinical Oncology Annual Meeting
July 19, 2023 July 19, 2023Categories Ongoing TrialsA closer look at ECOG-ACRIN’s men’s cancer trialsThese trials are exploring new treatment approaches for adults with prostate or penile cancer
September 26, 2022 September 26, 2022Categories Trial ResultsTrial Results: ECOG-ACRIN research round-up – Fall 2022Summaries of recently reported ECOG-ACRIN research results
June 28, 2022 June 28, 2022Categories Trial ResultsTrial Results: ECOG-ACRIN research round-up – Summer 2022Summaries of recently reported ECOG-ACRIN research results
September 20, 2021 September 20, 2021Categories Ongoing TrialsOngoing Trial: The INDICATE trial is testing ways to personalize treatment for men with prostate cancer that returns after surgeryThe study will assess if PET/CT scans can help identify patients who may have better outcomes from adding customized therapy to standard-of-care treatment
June 24, 2021 June 24, 2021Categories New TrialsNow Enrolling: Clinical trial EA8184 is exploring if green tea extract pills can help reduce the progression of prostate cancerThis study will evaluate the effects and safety of green tea catechins in men on active surveillance for prostate cancer
March 3, 2021 March 3, 2021Categories Trial ResultsTrial Results: Recent ECOG-ACRIN researchOver the last several months, ECOG-ACRIN researchers have published the results of at least seven clinical trials